Metraipolis › archive › dc_d6dee98c956e

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study — Europe PMC PMID:42149363

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42149363
DOI
10.1007/s15010-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-02T05:27:25.352Z
SHA-256 of the archived text
04685869cf241c82240b03f10d008acf44a1cb21a9cf143705d5a626cb8448a6
Stable URL of this page
https://metraipolis.com/documento/dc_d6dee98c956e

How to cite

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study — Europe PMC PMID:42149363 — Europe PMC (en), https://europepmc.org/article/MED/42149363 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d6dee98c956e (Metraipolis archive dc_d6dee98c956e, sha256 04685869cf241c82240b03f10d008acf44a1cb21a9cf143705d5a626cb8448a6)
BibTeX
@misc{dcd6dee98c956e,
  title = {Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study — Europe PMC PMID:42149363},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42149363},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d6dee98c956e; sha256 04685869cf241c82240b03f10d008acf44a1cb21a9cf143705d5a626cb8448a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42149363. Agents can read the archived copy with the MCP tool read_document.